Alvotech gets FDA VAI classification for Iceland plant | ALVO SEC Filing
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16…
Celltrion’s Remsima Captures 70% of European Market
Celltrion’s (068270.KS) autoimmune disease treatment Remsima has captured a 70% share of the European market, with both flagship…
Alvotech reports completion of FDA inspection in Iceland
Alvotech (NASDAQ:ALVO) announced Monday that the U.S. Food and Drug Administration (FDA) has completed a routine cGMP (current…
SteinCares and Shilpa Biologicals to expand access to biosimilars across Latin America
SteinCares and Shilpa Biologicals to expand access to biosimilars across Latin America February 25, 2026 | Wednesday |…
Icelandic BioTech Alvotech secures €100 million term loan facility to bolster liquidity and R&D investment
Alvotech, a Reykjavík-based BioTech company specialising in the development and manufacture of biosimilar medicines, has secured a €100…
South Korea’s Celltrion expects minimal impact from Trump’s drug pricing order
Seoul: Celltrion, a leading South Korean biopharmaceutical company, on Thursday said its business will remain largely unaffected by…